Board of Directors

The Foundation’s Board of Directors is comprised of highly successful thought leaders with extensive experience in science, biomedical research, healthcare, medical device and pharmaceutical industries, finance, education, and government and regulatory agencies. It is the enthusiasm and energy of this group that propels the Foundation forward.

boardPhotobattenDOROTHY BATTEN

Dorothy Batten is the founder of iThrive, a non-profit initiative which fosters the adoption of positive psychology and social emotional learning in video games and apps for adolescents to promote resilience, self-awareness, and emotional wellbeing. Ms. Batten is also the President of the D.N. Batten Foundation and DTMP, LLC, a real estate investment company, and was a former director of Landmark Media Enterprises LLC of Norfolk, Virginia. She serves on numerous nonprofit boards, including the Women's Initiative, RARE, and the UVA Alumni Board of Trustees. Ms. Batten received her undergraduate degree from Hollins University and her MBA from the University of Virginia.

 

boardPhotodevink

LODEWIJK J.R. DE VINK

Mr. de Vink served as Founding Partner of Blackstone Health Care Partners, was formerly the Chairman, President and Chief Executive Officer of Warner-Lambert Company and was the former President of Schering-Plough International. He has previously served on the Board of Directors of Roche, Flamel Technologies S.A., Sotheby's International Advisory Board and was a member of the European Advisory Council of Rothschild & Cie. Currently, Mr. de Vink is serving in Senior Advisory roles to Wendel North America and Guggenheim Securities. He is a board member of the New York Philharmonic and the Jupiter Medical Clinic and Foundation, Jupiter, FL.

 

boardPhotoGeneFife EUGENE V. FIFE

Mr. Fife is the founding principal of Vawter Capital LLC, a private investment company. While a partner of Goldman Sachs, he served on the Management Committee and was chairman of Goldman Sachs International. Mr. Fife currently is a director at Accudyne Industries, a producer of engineered pumps and compressors for energy business and other industries. Mr. Fife was a member of the board of directors of Caterpillar from 2002 to 2012. During that time he served as chair of the Audit Committee and, at the time of his retirement from the board, was chair of the Governance Committee and presiding director. He was non-executive chairman of Eclipsys, a provider of healthcare information systems that merged with Allscripts in 2010. Other boards on which he has served include Office Depot, a global supplier of office products and services, and Cequel Corporation, a provider of residential and commercial cable services. He currently is chair of the Governing Council of the Miller Center of Public Affairs, an affiliate of the University of Virginia. Mr. Fife received his undergraduate degree from Virginia Tech and his M.B.A. from the University of Southern California.

 

GrishamJOHN GRISHAM

Mr. Grisham is an internationally acclaimed author whose works include several No. 1 best sellers. Nine of his books have been made into successful motion pictures. Prior to his career as a writer, he practiced law for nearly 10 years, specializing in criminal defense and personal injury litigation. He served in the Mississippi House of Representatives from 1984 until 1990. Mr. Grisham serves on the Board of Directors for the Innocence Project and was closely involved with establishing the “Rebuild the Coast” Fund for Gulf Coast relief in the wake of Hurricane Katrina. Mr. Grisham received his undergraduate degree from Mississippi State University and his JD from the University of Mississippi School of Law.

 

Bill Hawkins for web2WILLIAM A. HAWKINS, III

Bill Hawkins is the retired Chairman and CEO of Medtronic and currently Lead Director of Immucor, Inc., a leading provider of transfusion and transplantation diagnostic products worldwide. Hawkins is the Chairman and co-Founder of the Medical Device Innovation Consortium (MDIC), and past-president of the American Institute of Medical and Biological Engineering (AMIBE). He was recently elected to the National Academy of Engineering, is an AIMBE Fellow, and is active on public and private boards as well as not-for-profit boards. Hawkins received his bachelor's degree in electrical and biomedical engineering from Duke University, where he also conducted medical research in pathology. He also earned an MBA from the University of Virginia Darden School of Business.

 

altDANIEL P. JORDAN, PhD

Dr. Jordan is a founding partner of Bryan and Jordan Consulting, LLC and President Emeritus of the Thomas Jefferson Foundation, which owns and operates Monticello. He is a former scholar in residence at the University of Virginia and a former professor of history at Virginia Commonwealth University. In 2009, Dr. Jordan was the James Marston Fitch Resident for Historic Preservation at the American Academy in Rome. Dr. Jordan has published three books and more than 70 articles, essays, and reviews. He is a member of the governing board of the Gilder Lehrman Institute of American History, a former Vice Chairman of the National Trust for Historic Preservation, a former Chairman of The National Park Service Advisory Board and has served on planning groups for Independence Hall, the White House, and the United States Capitol. He received his undergraduate degree from the University of Mississippi and his PhD from the University of Virginia, where he was elected to Phi Beta Kappa.

 

boardPhotokassellNEAL F. KASSELL, MD

Dr. Kassell is the founder and chairman of the Focused Ultrasound Foundation and a Professor of Neurosurgery at the University of Virginia, where he was co-chair until 2006. He has published more than 500 scientific papers and book chapters, and his research has been supported by over $30 million in NIH and industry grants and contracts. A member of numerous medical societies in the United States and abroad, he has served on many standing and ad hoc committees of the National Institutes of Health and in an editorial capacity for a variety of academic journals. In April 2016, he was named to the Blue Ribbon Panel of Vice President Joe Biden’s Cancer Moonshot Initiative. Dr. Kassell is a founder of numerous private ventures including Interax, Inc.; the Virginia Neurological Institute; Multimedia Medical Systems, Inc.; the Neuroclinical Trials Center; the NeuroVenture Fund; and MedSpecialists.net. He has served on a number of corporate and not-for-profit boards, including Eclypsis Corporation; INC Research; the Prostate Cancer Foundation; InSightec, Ltd.; the Expedition Trust Company; Tuesday Evening Concert Series and Virginia National Bank, and is currently a director of the La Gesse Foundation and the Focused Ultrasound Foundation. He is a shareholder in Insightec, Ltd., where he also served on the board until 2012. Dr. Kassell received his undergraduate and medical education at the University of Pennsylvania.

 

Ned Kelly smEDWARD J. "NED" KELLY, III

Mr. Edward J. “Ned” Kelly, III, brings decades of experience with preeminent financial organizations. He is currently on the board of directors of CSX Corporation, MetLife and XL Group. Kelly served as chairman of the institutional clients group at Citigroup Inc. He joined Citigroup in 2008 and held positions including chairman of global banking, vice chairman, and CFO. Prior to Citigroup, Kelly held leadership roles at The Carlyle Group, The PNC Financial Services Group, Inc., Mercantile Bankshares Corp., and JPMorgan Chase & Co. Kelly has served on several boards including The Hartford Financial Services Group, Inc., The Hershey Company, Paris Re Holdings Ltd., Axis Capital Holdings Limited, Constellation Energy Group (now a subsidiary of Exelon Corporation), CIT Group Inc., New York City Ballet, Securities Industry and Financial Markets Association, the University of Virginia Law School Foundation, Johns Hopkins University, Johns Hopkins School of Medicine, Baltimore Symphony Orchestra and Baltimore Museum of Art. Kelly received his Bachelor of Arts degree in English from Princeton University and his Juris Doctor degree from the University of Virginia School of Law.

 

Ed MillerEDWARD D. MILLER, MD

Dr. Edward D. Miller retired as CEO and chief fundraiser of John Hopkins Medicine, dean of The John Hopkins University School of Medicine and Vice President for Medicine of the John Hopkins University in June 2012. Dr. Miller joined John Hopkins in 1994 and was named interim dean of the school of medicine in 1996. Prior to this, Dr. Miller served at Columbia University for eight years and spent 11 years at the University of Virginia. Dr. Miller received his AB from Ohio Wesleyan University and his medical degree from the University of Rochester School of Medicine and Dentistry.

 

boardPhotomollFREDERIC H. MOLL, MD

Dr. Moll is a pre-eminent leader in the development and commercialization of innovative medical devices. His start-up ventures have included Intuitive Surgical, Inc., manufacturer of the highly successful da Vinci Surgical System. He also started Origin Medsystems, Inc., a laparoscopic instruments and devices company, and Endotherapeutics Corporation, manufacturer of the safety trocar, which Dr. Moll invented while training as a surgeon. He currently serves as Chairman of the Board of Auris, Inc., a medical robotics company he founded in 2011.

Dr. Moll received his MD from the University of Washington and trained in surgery at Virginia Mason Hospital in Seattle. He also earned a bachelor's degree in economics from the University of California at Berkeley and a master's degree in management from Stanford University in Palo Alto, California. He is a distinguished lecturer and has authored numerous scientific articles.

 

boardPhotorusckowskiSTEVE RUSCKOWSKI

Mr. Rusckowski is President and CEO of Quest Diagnostics. From November 2006 to May 2012, he was the Executive Vice President and Chief Executive Officer of Philips Healthcare and also served as a member of the Philips Board of Management. He was previously the CEO of the Imaging Systems business group of Philips Healthcare. Before joining Philips, Mr. Rusckowski held numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. He was the Senior Vice President and General Manager of Agilent’s Healthcare Solutions Group when Philips acquired this business in 2001. Most recently, he was elected to the Board of Directors of Xerox. Mr. Rusckowski was born in 1957 in the United States and holds a Bachelor of Science in Mechanical Engineering from Worcester Polytechnic Institute and a Masters in management science from M.I.T.’s Sloan School of Management.

 
Steger 165CHARLES STEGER, PHD

Dr. Charles W. Stegar was the 15th president of Virginia Polytechnic Institute and State University (Virginia Tech), where he studied architecture and earned a Ph.D. in engineering. Dr. Steger’s presidency was one of the longest and most impactful terms in Virginia Tech history. He created interdisciplinary institutes, grew the research portfolio by 250 percent, oversaw the creation of a medical school and concluded a fundraising campaign that exceeded $1 billion. In 2003, he was appointed by Governor Warner to chair the Steering Committee on Research Capabilities and Centers of Excellence. He chaired the board for the Center for Innovative Technology, served on the board of the Jefferson National Lab, served on the Northern Virginia Technology Council, founded the World Institute for Disaster Risk Management with colleagues in Switzerland, and was Vice President of the Council of Presidents and chair of the Executive Committee of the Southeastern Universities Research Association. Currently, Dr. Stegar serves as Executive Director of the Global Forum on Urban and Regional Resilience, a member of the boards of the National Institute of Building Sciences and the Economic Club of Washington, and is a Fellow in the American Institute of Architects.
 

ANDREW VON ESCHENBACH, MDboardPhotoeschenbach

Dr. von Eschenbach currently serves as President of Samaritan Health Initiatives, Inc. and as an Adjunct Professor at University of Texas MD Anderson Cancer Center. He is the former Commissioner of the U.S. Food and Drug Administration and former Director of National Cancer Institute at the National Institutes of Health. He is the former President of the American Cancer Society and was a founding member of the National Dialog on Cancer. Dr. von Eschenbach serves on the board of directors and is a shareholder for Histosonics. In 2006, TIME Magazine named him one of the “100 most influential people to shape the world,” and he was selected in both 2007 and 2008 as one of the Modern Healthcare/Modern Physician’s “50 Most Powerful Physician Executives in Healthcare.” Dr. von Eschenbach received his undergraduate degree from St. Joseph’s University and his MD from Georgetown University.

 

CARL P. ZEITHAML, PhDcarl sm

Dr. Zeithaml is serving his fourth term as the Dean and F.S. Cornell Professor of Free Enterprise in the McIntire School of Commerce at the University of Virginia. He joined the McIntire School in 1997 after spending more than a decade at the Kenan-Flagler Business School of the University of North Carolina-Chapel Hill. He received a doctorate in strategic management from the University of Maryland, an M.B.A. from the University of Florida, specializing in health care management, and a B.A. in economics from the University of Notre Dame. 

Dean Zeithaml specializes in the field of strategic management with an emphasis on global and competitive strategy. He conducts research on international expansion strategies, knowledge-based sources of competitive advantage, corporate political activity, strategic decision making, the strategic role of the board of directors, the implementation of diversification strategies, and organizational transformation. Dean Zeithaml is a board member of Dollar Tree Stores, Inc. and previously served on the Management Oversight Committee of the Global Real Estate Special Opportunities Fund managed by Deutsche Bank.

For more information, see our Board of Directors Governance Details and review our CEO Compensation Determination policy.


 
     

Share this page